AI stocks have led the market in recent years. But as investors question the costs and future returns of the AI boom, some are looking for options outside the tech sector.
Bristol-Myers-Squibb (BMY), Colgate-Palmolive (CL), and Gilead Sciences (GILD) each are remarkable for their own reasons: essential medicines, everyday household products, and proven treatments for serious illnesses. While none of these companies can avoid market swings, healthcare and consumer products are often defensive in nature, offering more stability than AI stocks. All three also pay quarterly dividends, adding to their appeal for income-seeking investors looking beyond AI stocks.
